Medicofarma Biotech SA (WSE:MDB)
0.6360
-0.0280 (-4.22%)
At close: Oct 10, 2025
Medicofarma Biotech Market Cap
Medicofarma Biotech has a market cap or net worth of 43.23 million as of October 10, 2025. Its market cap has increased by 24.22% in one year.
Market Cap
43.23M
Enterprise Value
46.37M
Revenue
279.31K
Ranking
n/a
PE Ratio
n/a
Stock Price
0.64
Market Cap Chart
Since January 30, 2009, Medicofarma Biotech's market cap has increased from 6.50M to 43.23M, an increase of 565.14%. That is a compound annual growth rate of 12.01%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Oct 10, 2025 | 43.23M | 63.92% |
Dec 30, 2024 | 26.38M | -64.24% |
Dec 29, 2023 | 73.76M | -6.06% |
Dec 30, 2022 | 78.51M | -32.05% |
Dec 30, 2021 | 115.54M | 483.23% |
Dec 30, 2020 | 19.81M | 848.05% |
Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
Dec 27, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Diagnostyka | 6.11B |
NEUCA | 3.22B |
Synektik Spólka Akcyjna | 2.27B |
Voxel | 1.85B |
Celon Pharma | 1.22B |
Selvita | 662.63M |
Centrum Medyczne ENEL-MED | 523.19M |
Ryvu Therapeutics | 491.93M |